ORAI1 and breast cancer: Expression of the ORAI1 Ca2+ influx channel is higher in breast cancers of the basal molecular subtype, which are often triple‐negative (i.e., do not express estrogen, progesterone, and HER2 receptors) compared to nonbasal breast cancers (McAndrew et al., 2011).